iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Update

Posted by ABMN Staff on Jan 28th, 2026

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 6,747 shares, an increase of 428.3% from the December 31st total of 1,277 shares. Based on an average trading volume of 40,604 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the shares of the company are short sold. Currently, 0.1% of the shares of the company are short sold. Based on an average trading volume of 40,604 shares, the short-interest ratio is presently 0.2 days.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

Several hedge funds have recently modified their holdings of IDNA. Triumph Capital Management purchased a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the 3rd quarter valued at about $35,000. Flow Traders U.S. LLC bought a new position in iShares Genomics Immunology and Healthcare ETF in the second quarter worth approximately $931,000. Ameriprise Financial Inc. lifted its stake in iShares Genomics Immunology and Healthcare ETF by 8.4% in the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after acquiring an additional 5,540 shares during the period. Finally, Portland Global Advisors LLC purchased a new stake in shares of iShares Genomics Immunology and Healthcare ETF in the 2nd quarter worth approximately $2,099,000.

iShares Genomics Immunology and Healthcare ETF Stock Performance

IDNA opened at $29.65 on Wednesday. iShares Genomics Immunology and Healthcare ETF has a fifty-two week low of $17.26 and a fifty-two week high of $30.30. The stock has a market cap of $148.25 million, a price-to-earnings ratio of 14.76 and a beta of 1.07. The firm’s fifty day moving average is $27.19 and its 200 day moving average is $24.67.

About iShares Genomics Immunology and Healthcare ETF

(Get Free Report)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.